Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

May 5, 2023

Study Completion Date

June 20, 2023

Conditions
Prediabetic State
Interventions
DIETARY_SUPPLEMENT

Pep2dia

700 mg Pep2Dia® 15 min prior to breakfast and 700 mg Pep2Dia® 15 min prior to dinner

DIETARY_SUPPLEMENT

Placebo

700 mg placebo 15 min prior to breakfast and 700 mg placebo 15 min prior to dinner

Trial Locations (1)

Unknown

Biotesys, Esslingen am Neckar

All Listed Sponsors
collaborator

BioTeSys GmbH

OTHER

lead

Ingredia S.A.

INDUSTRY